Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, indicating a deployment update. This does not modify the study details or other user-facing content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a page version update without changes to the study details.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision tag updated from v3.5.2 to v3.5.3, indicating a minor build update. It does not alter study details or other visible content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision tag updated to v3.5.2; the previous tag v3.5.0 has been removed.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This change does not affect study details or page content.SummaryDifference0.0%

Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.